A | Previously patients were required to receive authorization for cannabis-based medicines from the Federal Office of Public Health. The new regulation will make it easier for people with chronic illnesses and pain to receive timely treatment, without having to go through tiring administrative procedures. Although, the authorities have not found sufficient evidence to reimburse cannabis-based medicines through the compulsory healthcare insurance, allowing their reimbursements only in exceptional cases.,The cultivation and production of cannabis for medical purposes will be controlled by the state's medical watchdog, Swissmedic, which will act in accordance with the UN Single Convention on Narcotic Drugs of 1961.,Any use or selling of cannabis for non-medical purposes is still prohibited in the country.。 8月23日，蓝思科技在电话会议上表示，公司报告期内新增国际知名客户运动相机组装业务，目前两个项目已进入量产爬坡阶段，另有新的NPI项目正在验证导入，预计年内实现量产。上述新型摄影消费电子产品市场渗透率快速提升，出货量大幅增长，公司大规模、高精度的自动化产线显著提升组装良率和效率，协助客户顺利实现产品大规模出货。（证券时报）原文链接。
Current article:http://c86op.yepenchunshouzuiwai.shop/chn/yi63zn.html
Published on:17:32:51
